Hi {{firstname|everyone}},
Bridgepoint just bought MyDentist for an enterprise value of £800 million. With an EBITDA of around £74 million, this puts the deal at an inferred 10x multiple, a significant benchmark for the UK dental sector.
This isn’t just another transaction.
It sets the tone for how the market is valuing dental groups in 2025 and what private equity will pay for businesses, big or small.
In our latest analysis, we break down:
Why the 10x multiple matters (especially if you're aiming for a higher exit)
What Bridgepoint might do next and what smaller groups can learn from it
How the M&A landscape has changed since their last exit in 2017
👉 Read the full blog here:
If you’re running a dental group and thinking about growth or exit, this is essential reading.
Cheers,
Arun